Literature DB >> 18635501

A new knee surgery model in rats to evaluate functional measures of postoperative pain.

Asokumar Buvanendran1, Jeffrey S Kroin, Maruti R Kari, Kenneth J Tuman.   

Abstract

INTRODUCTION: With the increase in the number of total knee surgeries being performed, postoperative analgesic management remains a challenge. We used a new animal knee surgery model to characterize pain-related behavior in the rat, and its therapeutic modulation with systemic and intrathecal drug treatment.
METHODS: Rats were anesthetized with isoflurane and an incision was made over the left knee to expose the patella tendon. The tendon was reflected aside and a 1.4-mm diameter, 0.5 mm deep hole was drilled in both the femur and tibia at 2 mm above and below the knee joint, respectively. The holes were filled with dental cement and the wound was closed. Sham surgery animals only had a skin incision. Some animals had previously been implanted with a lumbar intrathecal catheter for drug injection. At 24 h after surgery, animals received the following drugs systemically: i.p. morphine sulfate 0.3-1 mg/kg, i.p. ketorolac 2.5-20 mg/kg, p.o. celecoxib 10-50 mg/kg, i.p. ketamine hydrochloride 2.5-10 mg/kg, i.p. clonidine hydrochloride 25 microg/kg, p.o. pregabablin 10-20 mg/kg, or drug vehicle; or intrathecally: morphine sulfate 0.3-1 microg, ketorolac 4-80 microg, L-745,337 80 microg, pregabalin 15 microg, neostigmine 0.5 microg, or saline vehicle. Pain-related behavior was then assessed by recording exploratory spontaneous activity, in which vertical and horizontal light beam interruptions were automatically recorded to measure rearing activity and ambulation for 60 min. Data were compared using analysis of variance with the Tukey-B post hoc test.
RESULTS: The model demonstrated deficits in rearing and ambulation compared with sham skin incision control animals on postsurgery days 1-3. Systemic and intrathecal morphine improved rearing and ambulation, with knee surgery/ morphine rats displaying as much activity as sham skin incision/vehicle animals, whereas knee surgery/vehicle rats showed decreased activity. Systemic ketorolac 20 mg/kg improved rearing and ambulation, with knee surgery/ketorolac rats showing increased activity compared with knee surgery/vehicle animals. Intrathecal ketorolac 4-40 microg did not increase rearing or ambulation, but the 80 microg dose was effective. Other drugs tested, systemically or intrathecally, did not restore activity to normal levels.
CONCLUSION: This study presents a new simple, reproducible rat model to assess function and discomfort after knee surgery, and one that responds to therapeutic interventions. In this knee surgery model, both systemic and intrathecal administration of either morphine or ketorolac caused reversal of the deficits in rearing and ambulatory behavior at 24 h postsurgery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635501     DOI: 10.1213/ane.0b013e3181732f21

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

1.  Development of an Experimental Animal Model for Lower Back Pain by Percutaneous Injury-Induced Lumbar Facet Joint Osteoarthritis.

Authors:  Jae-Sung Kim; Kasra Ahmadinia; Xin Li; John L Hamilton; Steven Andrews; Chris A Haralampus; Guozhi Xiao; Hong-Moon Sohn; Jae-Won You; Yo-Seob Seo; Gary S Stein; Andre J Van Wijnen; Su-Gwan Kim; Hee-Jeong Im
Journal:  J Cell Physiol       Date:  2015-11       Impact factor: 6.384

2.  Using the Mouse Grimace Scale to reevaluate the efficacy of postoperative analgesics in laboratory mice.

Authors:  Lynn C Matsumiya; Robert E Sorge; Susana G Sotocinal; John M Tabaka; Jeffrey S Wieskopf; Austin Zaloum; Oliver D King; Jeffrey S Mogil
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-01       Impact factor: 1.232

3.  Ketorolac reduces spinal astrocytic activation and PAR1 expression associated with attenuation of pain after facet joint injury.

Authors:  Ling Dong; Jenell R Smith; Beth A Winkelstein
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

4.  Validation of orthopedic postoperative pain assessment methods for dogs: a prospective, blinded, randomized, placebo-controlled study.

Authors:  Pascale Rialland; Simon Authier; Martin Guillot; Jérôme R E Del Castillo; Daphnée Veilleux-Lemieux; Diane Frank; Dominique Gauvin; Eric Troncy
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

5.  Pregabalin in the treatment of inferior alveolar nerve paraesthesia following overfilling of endodontic sealer.

Authors:  Oscar Alonso-Ezpeleta; Pablo J Martín; José López-López; Lizett Castellanos-Cosano; Jenifer Martín-González; Juan J Segura-Egea
Journal:  J Clin Exp Dent       Date:  2014-04-01

6.  Efficacy of Intrathecal Morphine in a Model of Surgical Pain in Rats.

Authors:  Aurelie Thomas; Amy Miller; Johnny Roughan; Aneesa Malik; Katherine Haylor; Charlotte Sandersen; Paul Flecknell; Matthew Leach
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

Review 7.  Emotional and Motivational Pain Processing: Current State of Knowledge and Perspectives in Translational Research.

Authors:  Susanne Becker; Edita Navratilova; Frauke Nees; Stefaan Van Damme
Journal:  Pain Res Manag       Date:  2018-07-18       Impact factor: 3.037

8.  Voluntary movements as a possible non-reflexive pain assay.

Authors:  Hawon Cho; Yongwoo Jang; Byeongjun Lee; Hyeyoun Chun; Jooyoung Jung; Sung Min Kim; Sun Wook Hwang; Uhtaek Oh
Journal:  Mol Pain       Date:  2013-05-20       Impact factor: 3.395

9.  Intrathecal ketorolac enhances intrathecal morphine analgesia following total knee arthroplasty.

Authors:  Gabriela R Lauretti; Claudia C F Righeti; Anita L Mattos
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10

10.  Contribution of diacylglycerol lipase β to pain after surgery.

Authors:  Jennifer Luk; Yong Lu; Amanda Ackermann; Xiaoxue Peng; Diane Bogdan; Michelino Puopolo; David E Komatsu; Simon Tong; Iwao Ojima; Mario J Rebecchi; Martin Kaczocha
Journal:  J Pain Res       Date:  2018-03-05       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.